Imugene LtdHere is the public summary page for Imugene Ltd. Please login to see the complete information for Imugene Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Imugene Ltd stacks up relative to its peers. |
| Darwin Score | -31 |
| Ticker | IMU |
| Latest Price | 0.38 AUD as of close on 16-Jul-2025 |
| 3 Month price range | 0.37 to 0.88 AUD |
| Market Capitalisation | 84.36Mn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA, a combination of genomic sequences from various vaccinia virus strains to generate potent virus in phase 1 clinical trial for mixed advanced solid tumours; and CF33 CD19 chimeric antigen receptor T cells therapies to target solid tumours in phase 1 study. The company also develops CF33 oncolytic virotherapy CHECKvacc in phase 1 clinical trial for triple negative breast cancer; HER-VAXX, a B-cell immunotherapy cancer vaccine completed phase 2 clinical trial to target metastatic and advanced gastric cancer; PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling in phase 2 clinical trial to target non-small cell lung cancer; and NeoPOLEM in phase 2 study for MSI-high colorectal cancer. The company has a research collaboration with NeoImmuneTech to enhance cancer treatments. Imugene Limited is based in Sydney, Australia. See More ... |
| Company URL | https://www.imugene.com |
| See Darwins Full Analysis for Imugene Ltd |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Imugene Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -13 |
| Sentiment | News and Candle Patterns. | -2 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -17 |
Alerts
There are 17 live alerts for Imugene Ltd.
- Oversold - The 5 month RSI is +2.0. (Positive)
- Divergence: Px Down & OBV Up last 10 days. This alert has occurred 154 times over the last last year. The average forward returns are -1.5% over 5 days, -4.1% over 10 days, -7.3% over 15 days and -10.3% over 20 days. (Positive)
- Divergence: Px Down & 30d RSI Up last 20 days. This alert has occurred 63 times over the last last year. The average forward returns are -1.0% over 5 days, -4.3% over 10 days, -6.8% over 15 days and -9.1% over 20 days. (Positive)
- 5d RSI Oversold. This alert has occurred 97 times over the last last year. The average forward returns are -2.7% over 5 days, -3.5% over 10 days, -7.6% over 15 days and -10.8% over 20 days. (Negative)
- Cross Over (Down): 5dma . This alert has occurred 31 times over the last last year. The average forward returns are -2.0% over 5 days, -5.6% over 10 days, -7.5% over 15 days and -10.3% over 20 days. (Negative)
- Cross Over (Down): 20dma . This alert has occurred 14 times over the last last year. The average forward returns are -2.8% over 5 days, -6.9% over 10 days, -4.2% over 15 days and -5.8% over 20 days. (Negative)
- High Volume 2x 130dma. This alert has occurred 22 times over the last last year. The average forward returns are -3.1% over 5 days, -9.4% over 10 days, -13.2% over 15 days and -15.6% over 20 days. (Positive)
- Volume is 9.0x 20 day average. Significant move down of -10.6%. (Negative)
- Oversold - The 30 week RSI is +24.8. (Positive)
- Oversold - The 15 month RSI is +21.1. (Positive)
- Candle Pattern :: Significant Gap Down (Bearish) (Negative) (Negative)
- Divergence: Px Down & OBV Up last 65 days. This alert has occurred 239 times over the last last year. The average forward returns are -2.4% over 5 days, -5.0% over 10 days, -7.8% over 15 days and -10.5% over 20 days. (Positive)
- Divergence: Px Down & 15d RSI Up last 20 days. This alert has occurred 74 times over the last last year. The average forward returns are -2.0% over 5 days, -6.3% over 10 days, -9.2% over 15 days and -12.4% over 20 days. (Positive)
- Divergence: Px Down & OBV Up last 20 days. This alert has occurred 185 times over the last last year. The average forward returns are -1.8% over 5 days, -4.5% over 10 days, -7.9% over 15 days and -11.2% over 20 days. (Positive)
- Price crossing down through 5 day SMA. This alert has occurred 31 times over the last last year. The average forward returns are -2.0% over 5 days, -5.6% over 10 days, -7.5% over 15 days and -10.3% over 20 days. (Positive)
- High Volume 2x 65dma. This alert has occurred 21 times over the last last year. The average forward returns are -2.9% over 5 days, -9.4% over 10 days, -13.5% over 15 days and -15.6% over 20 days. (Positive)
- High Volume 2x 20dma. This alert has occurred 21 times over the last last year. The average forward returns are -3.7% over 5 days, -10.5% over 10 days, -14.5% over 15 days and -17.3% over 20 days. (Positive)
Peer Comparison
There are 12 peers of Imugene Ltd.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | +6 |
| Arovella Therapeutics Ltd (ALA) | Biotechnology | +22 |
| CSL Ltd (CSL) | Biotechnology | +19 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | +4 |
| Mesoblast Ltd (MSB) | Biotechnology | +12 |
| Opthea Ltd (OPT) | Biotechnology | -10 |
| PYC Therapeutics Ltd (PYC) | Biotechnology | +22 |
| Paradigm Biopharmaceuticals Ltd (PAR) | Biotechnology | +4 |
| Polynovo Ltd (PNV) | Biotechnology | +4 |
| Race Oncology Ltd (RAC) | Biotechnology | -20 |
| Telix Pharmaceuticals Ltd (TLX) | Biotechnology | +10 |
| Tissue Repair Ltd (TRP) | Biotechnology | +7 |
Share 
